CDK2, CDC2, Cell devision kinase 2, Cell division protein kinase 2, CDC2-related protein kinase, Cell division kinase 2, p33 protein kinase, p33(CDK2), CDKN2, Cyclin-dependent kinase 2
Product description
Cyclin-dependent kinase 2 (CDK2), a CDC2/CDK-type protein kinase, regulates cell-cycle transition from G1 to S phase. CDK2 activation requires formation of a heterodimer with cyclin A, D, or E and phosphorylation by CAK. CDK2 inhibition results from association with p21Cip1 (CDKN1A) and p27Kip1 (CDKN1B). Two alternatively spliced variants and multiple transcription initiation sites have been reported. Inhibition of CDK2 has been suggested to help prevent chemotherapy-induced alopecia in cancer patients.
Immunogen
CDK2 monoclonal antibody was raised against recombinant CDK2 (Human).
Key Feature
Clonality
Monoclonal
Isotype
IgG
Host Species
Mouse
Tested Applications
ELISAIHCIPWB
CDK2 antibody can be used in immunohistochemistry starting at 10 μg/mL.: